What is the impact of the NICE Draft Guidance on Community and Primary Care NAFLD Screening with FibroScan not analyzing the long-term impact of a decision not to compensate on health care in the UK?
Does the NICE Draft Guidance and methodology reveal a bad fit between the NICE mode of analysis and wellness-oriented solutions like early NAFLD screening?
What can we learn about prospects for community screening for NAFLD from the NICE draft guidance on this issue?
Jeff Lazarus And Jörn Schattenberg of the Innovations in NAFLD Care 2022 Series join the Surfers to consider innovative elements for a program like this along with the outcomes they would like these programs to produce.
Jeff Lazarus And Jörn Schattenberg of the Innovations in NAFLD Care 2022 Series join the Surfers to discuss the structural healthcare issues that are shaping the Fatty Liver pandemic and why education is such an important part of the solution.
Co-chairs Jeff Lazarus and Jörn Schattenberg of the Innovations in NAFLD Care 2022 Series join the Surfers to review the initiative’s key elements and patient awareness goals.
Co-chairs of the Innovations in NAFLD Care 2022 initiative join the Surfers to review the initiative’s goals and agenda.
Jeff Lazarus and Jörn Schattenberg join the Surfers to discuss their new Innovations in NAFLD Care 2022 webinar and hybrid meeting series in a session whose dialogue blends medical, economic and public health discussions.
This episode uses quotes from Surfing the NASH Tsunami’s NASH-TAG 2022 coverage and comments from Roger Green to explore what we learned there about combination therapies.
Donna Cryer and Scott Friedman share perspectives on where all things NASH and NAFLD are heading in a conversation with Roger Green.
